More Info

Investor Information

About Our Investors


InCarda’s lead investor is Morningside Ventures. Other investors include a consortium of physicians and other health care and high tech professionals. Morningside is a diversified investment group founded in 1986. It is engaged primarily in private equity and venture capital investments. The group has investments in North America, Europe, and since 1992, in mainland China. Morningside is an active investor in early-stage companies founded around novel life science and medical technology.

Disease Information

About Paroxysmal Atrial Fibrillation (PAF)

Atrial fibrillation (AF) is the most commonly encountered, sustained cardiac arrhythmia (abnormal heart rhythm), and involves the two upper chambers (atria) of the heart. Its name comes from the fibrillating (i.e. quivering) of the heart muscles of the atria instead of a coordinated contraction.

Paroxysmal atrial fibrillation (PAF) is a type of AF where episodes terminate spontaneously in less than 7 days, usually in less than 24 hours. About 1 in 4 people with paroxysmal atrial fibrillation eventually develop the permanent form of the condition.

The causes of PAF aren’t always known. They can be similar to causes of chronic AF, although most people with PAF have normal hearts. Common symptoms of PAF can include:

  • Racing heartbeat
  • A fluttering feeling in the chest
  • Chest pain or pressure
  • Feeling out of breath
  • Weakness or tiredness
  • Dizziness and sweating
  • Faintness or light-headedness

People with PAF appear to be at just as high a risk of developing blood clots as those with chronic AF.

More about our PAF Product